Public Research Library
Specialties:
Most Popular Reports:
- Laser Body Sculpting SmartLipo-Trends in Use
- Essure Permanent Birth Control
- Oral Contraceptives Market Evaluation
- Trends and Forecast of Dental Implant Cases
- Avastin and the AVADO Trial Survey
Newest Reports:
Drug Eluting Stents (DES) – Market Outlook
A Survey of Fifty Cardiologists
Deliverable: Survey in PowerPoint with key findings.
Study Description:
|
Topic |
Drug Eluting Stents |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Cardiology |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website § Approximately 15 minutes duration § 50 total respondents § Fielded online from January 9, 2008 to January 15, 2008 |
Objectives:
To understand current and future trends for the drug-eluting stent market and determine the perceptions of upcoming devices among a group of fifty interventional cardiologists. Secondary objectives include:
§ Determine current levels of use for drug-eluting stents (DES).
§ Gauge the perceptions of the upcoming drug-eluting stents (Endeavor and Xience).
§ Measure the influence of the upcoming drug-eluting stents on current practices.
§ Capture future potential product mix of the DES market.
Companies and Products Mentioned in This Report:
|
Company |
Ticker Symbol |
Product(s) |
|
Johnson and Johnson |
JNJ |
Cypher |
|
Boston Scientific |
BSX |
Taxus |
|
Medtronic |
MDT |
Endeavor |
|
Abbott |
ABT |
Xience |
Inclusion Criteria and Respondent Demographics:
|
Inclusion Criteria
|
§ US-based interventional cardiologists § Board-certified in specialty § 2 to 30 years of experience post-residency § Minimum of 75% professional time spent in clinical practice § Place at least 20 stent implants per month |
Reports become free one year after the publication date.
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |